AR and neoplasm: Fig. 5D and 5E show representative immunostaining of MYC-CaP/CR tumor sections, which demonstrate sections of tumor thatremained positive for AR nuclear expression, while adjacent sections of tumors exhibited loss of nuclear AR expression.